The Pennant Group, Inc. (PNTG) Financial Ratios
9 years of historical data (2017–2025) · Healthcare · Medical - Care Facilities
EV/EBITDA
↓
27.97
↓-37% vs avg
5yr avg: 44.39
30Y Low23.9·High87.9
P/FCF
↑
47.16
↑+71% vs avg
5yr avg: 27.54
30Y Low16.8·High40.9
P/B Ratio
↓
3.37
-1% vs avg
5yr avg: 3.42
30Y Low2.6·High17.3
ROE
↑
8.6%
↓+18% vs avg
5yr avg: 7.3%
30Y Low3%·High25%
Debt/EBITDA
↓
7.56
↓-53% vs avg
5yr avg: 16.12
30Y Low6.2·High37.5
Percentile shows where the current value sits in 30-year historical distribution. Sparklines show 5-year trend.
PNTG Valuation Multiples
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
The Pennant Group, Inc. trades at 42.5x earnings, 56% below its 5-year average of 96.3x, sitting at the 60th percentile of its historical range. Compared to the Healthcare sector median P/E of 22.3x, the stock trades at a premium of 91%. On a free-cash-flow basis, the stock trades at 47.2x P/FCF, 71% above the 5-year average of 27.5x.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Market Cap | $1.2B | $994M | $849M | $420M | $331M | $707M | $1.8B | $978M | — | — |
| Enterprise Value | $1.7B | $1.4B | $1.1B | $744M | $656M | $1.1B | $2.1B | $1.3B | — | — |
| P/E Ratio → | 42.54 | 33.51 | 37.35 | 31.64 | 49.91 | 329.24 | 111.65 | 384.53 | — | — |
| P/S Ratio | 1.31 | 1.05 | 1.22 | 0.77 | 0.70 | 1.61 | 4.49 | 2.89 | — | — |
| P/B Ratio | 3.37 | 2.66 | 2.72 | 2.89 | 2.64 | 6.19 | 17.35 | 13.76 | — | — |
| P/FCF | 47.16 | 37.81 | 28.00 | 16.82 | — | — | 40.86 | 344.51 | — | — |
| P/OCF | 25.68 | 20.59 | 21.59 | 12.70 | 36.61 | — | 34.96 | 102.41 | — | — |
P/E links to full P/E history page with 30-year chart
PNTG EV Ratios
Enterprise-value multiples — capital-structure-neutral measures of total business value
The Pennant Group, Inc.'s enterprise value stands at 28.0x EBITDA, 37% below its 5-year average of 44.4x. The Healthcare sector median is 14.4x, placing the stock at a 94% premium on an enterprise-value basis.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| EV / Revenue | — | 1.51 | 1.58 | 1.37 | 1.39 | 2.40 | 5.30 | 3.88 | — | — |
| EV / EBITDA | 27.97 | 23.87 | 24.81 | 24.55 | 37.17 | 111.54 | 87.91 | 138.49 | — | — |
| EV / EBIT | 32.62 | 27.34 | 28.64 | 29.16 | 51.59 | 226.35 | 108.35 | 231.55 | — | — |
| EV / FCF | — | 54.39 | 36.21 | 29.77 | — | — | 48.29 | 462.28 | — | — |
PNTG Profitability
Margins and return-on-capital ratios measuring operating efficiency
The Pennant Group, Inc. earns an operating margin of 5.4%. ROE of 8.6% is modest. ROIC of 5.6% represents adequate returns on invested capital.
Margins
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 12.9% | 12.9% | 13.5% | 12.3% | 12.4% | 11.1% | 14.0% | 13.2% | 14.8% | 12.9% |
| Operating Margin | 5.4% | 5.4% | 5.5% | 4.6% | 2.7% | 1.1% | 4.8% | 1.7% | 7.2% | 6.1% |
| Net Profit Margin | 3.1% | 3.1% | 3.2% | 2.5% | 1.4% | 0.6% | 4.0% | 0.8% | 5.5% | 3.9% |
Return on Capital
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| ROE | 8.6% | 8.6% | 9.9% | 9.9% | 5.5% | 2.5% | 18.3% | 3.7% | 25.1% | 16.5% |
| ROA | 3.6% | 3.6% | 3.7% | 2.5% | 1.3% | 0.5% | 3.3% | 0.9% | 16.8% | 11.2% |
| ROIC | 5.6% | 5.6% | 5.6% | 4.1% | 2.1% | 0.8% | 3.4% | 1.8% | 24.7% | 19.3% |
| ROCE | 7.3% | 7.3% | 7.3% | 5.5% | 2.8% | 1.1% | 4.6% | 2.4% | 31.6% | 24.8% |
PNTG Leverage & Debt
Solvency and debt-coverage ratios — lower is generally safer
The Pennant Group, Inc. carries a Debt/EBITDA ratio of 7.6x, which is highly leveraged (130% above the sector average of 3.3x). Net debt stands at $436M ($453M total debt minus $17M cash). Interest coverage of 7.8x is adequate, though a cyclical earnings downturn could tighten the margin of safety.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 1.21 | 1.21 | 0.88 | 2.27 | 2.60 | 3.11 | 3.15 | 4.71 | — | — |
| Debt / EBITDA | 7.56 | 7.56 | 6.17 | 10.88 | 18.51 | 37.48 | 13.52 | 35.32 | — | — |
| Net Debt / Equity | — | 1.17 | 0.80 | 2.22 | 2.58 | 3.06 | 3.15 | 4.70 | -0.00 | -0.00 |
| Net Debt / EBITDA | 7.28 | 7.28 | 5.63 | 10.68 | 18.40 | 36.93 | 13.52 | 35.28 | -0.00 | -0.00 |
| Debt / FCF | — | 16.59 | 8.21 | 12.95 | — | — | 7.43 | 117.77 | -0.00 | -0.00 |
| Interest Coverage | 7.83 | 7.83 | 5.51 | 4.31 | 3.33 | 2.41 | 15.45 | 13.83 | — | — |
PNTG Liquidity & Efficiency
Short-term solvency ratios and asset-utilisation metrics
A current ratio of 1.14x means The Pennant Group, Inc. can comfortably meet its short-term obligations, though there is limited excess liquidity.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.14 | 1.14 | 1.21 | 1.12 | 1.05 | 1.06 | 0.67 | 0.76 | 0.99 | 1.02 |
| Quick Ratio | 1.14 | 1.14 | 1.21 | 1.12 | 1.05 | 1.06 | 0.67 | 0.76 | 0.99 | 1.02 |
| Cash Ratio | 0.12 | 0.12 | 0.24 | 0.08 | 0.03 | 0.07 | 0.00 | 0.01 | 0.00 | 0.00 |
| Asset Turnover | — | 0.98 | 1.02 | 1.01 | 0.92 | 0.83 | 0.77 | 0.76 | 2.91 | 2.84 |
| Inventory Turnover | — | — | — | — | — | — | — | — | — | — |
| Days Sales Outstanding | — | 47.41 | 42.68 | 40.94 | 41.20 | 44.78 | 44.09 | 34.70 | 31.22 | 32.35 |
PNTG Shareholder Yields
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
The Pennant Group, Inc. does not currently pay a dividend and has no material buyback yield, reinvesting earnings back into the business. The earnings yield of 2.4% (inverse of P/E) provides a useful comparison to bond yields when assessing the stock's relative attractiveness to fixed income.
Dividends
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Yield | — | — | — | — | — | — | — | 1.2% | — | — |
| Payout Ratio | — | — | — | — | — | — | — | 455.6% | — | — |
Total Shareholder Return Metrics
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Yield | 2.4% | 3.0% | 2.7% | 3.2% | 2.0% | 0.3% | 0.9% | 0.3% | — | — |
| FCF Yield | 2.1% | 2.6% | 3.6% | 5.9% | — | — | 2.4% | 0.3% | — | — |
| Buyback Yield | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.3% | — | — |
| Total Shareholder Yield | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 1.5% | — | — |
| Shares Outstanding | — | $35M | $32M | $30M | $30M | $31M | $30M | $30M | $28M | $28M |
Peer Comparison
Compare PNTG with 10 similar companies in its peer group
| Company | Market Cap | P/E | EV/EBITDA | P/FCF | Gross Margin | Op Margin | ROE | ROIC | Debt/EBITDA |
|---|---|---|---|---|---|---|---|---|---|
 PNTGYou | $1B | 42.5 | 28.0 | 47.2 | 12.9% | 5.4% | 8.6% | 5.6% | 7.6 |
 ADUS | $2B | 18.7 | 12.5 | 17.5 | 32.5% | 9.7% | 9.3% | 8.8% | 1.3 |
 ENSG | $10B | 29.8 | 25.7 | 27.5 | 13.7% | 8.6% | 16.9% | 7.0% | 7.7 |
 NVST | $4B | 86.7 | 13.3 | 17.5 | 55.0% | 8.3% | 1.6% | 4.8% | 5.0 |
 NHC | $3B | 22.3 | 15.9 | 17.9 | 37.3% | 8.7% | 11.7% | 8.4% | 0.5 |
 SGRY | $2B | -23.5 | 10.0 | 9.6 | 23.1% | 11.8% | -2.2% | 4.1% | 7.1 |
 OPCH | $3B | 16.3 | 7.4 | 12.6 | 18.1% | 6.0% | 15.2% | 15.3% | — |
 HCSG | $2B | 27.5 | 22.4 | 11.5 | 13.0% | 2.6% | 11.7% | 9.0% | 0.4 |
 AVAH | $1B | 6.6 | 9.0 | 11.6 | 33.1% | 10.9% | 621.9% | 15.1% | 4.6 |
 UNH | $336B | 27.9 | 16.7 | 20.9 | 18.5% | 4.2% | 11.8% | 9.2% | 3.4 |
 HUM | $30B | 25.1 | 16.9 | 79.1 | 14.5% | 1.1% | 7.0% | 4.1% | 5.7 |
| Healthcare Median | — | 22.3 | 14.4 | 18.5 | 63.9% | -5.2% | -33.7% | -11.2% | 3.3 |
Peer selection based on competitive and market overlap. Compare multiple stocks →
Download Financial Ratios Data
Includes 30+ ratios · 9 years · Updated daily
See PNTG's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs PNTG Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare PNTG vs ADUS
Side-by-side business, growth, and profitability comparison vs Addus HomeCare Corporation.
Start ComparisonPNTG — Frequently Asked Questions
Quick answers to the most common questions about buying PNTG stock.
What is The Pennant Group, Inc.'s P/E ratio?
The Pennant Group, Inc.'s current P/E ratio is 42.5x. The historical average is 52.8x. This places it at the 60th percentile of its historical range.
What is The Pennant Group, Inc.'s EV/EBITDA?
The Pennant Group, Inc.'s current EV/EBITDA is 28.0x. This enterprise value multiple compares the company's total value (equity + debt - cash) to its EBITDA. The historical average is 39.7x.
What is The Pennant Group, Inc.'s ROE?
The Pennant Group, Inc.'s return on equity (ROE) is 8.6%. The historical average is 11.1%.
Is PNTG stock overvalued?
Based on historical data, The Pennant Group, Inc. is trading at a P/E of 42.5x. This is at the 60th percentile of its historical P/E range. Compare with industry peers and growth rates for a complete picture.
What are The Pennant Group, Inc.'s profit margins?
The Pennant Group, Inc. has 12.9% gross margin and 5.4% operating margin.
How much debt does The Pennant Group, Inc. have?
The Pennant Group, Inc.'s Debt/EBITDA ratio is 7.6x, indicating high leverage. A ratio above 4x may signal elevated financial risk.